Article

Treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: a systematic review and meta-analysis

2019-09-06

Abstract excerpt

<h4>Background: </h4> Prior to direct-acting antiviral (DAA) therapy, personalised medicine played an important role in the treatment of hepatitis C virus (HCV). Whilst simplified treatment strategies are central to treatment scale-up, some patients will benefit from treatment optimisation. This systematic review and meta-analysis explores treatment optimisation strategies in the DAA era. <h4>Methods: </h4>: We s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dca63c9b-6925-58d0-8060-24039958da52
DOI: 10.12688/wellcomeopenres.15411.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: a systematic review and meta-analysisDOI 10.12688/wellcomeopenres.15411.1Read

Treatment of hepatitis C: a systematic review.Semantic proximity Read

What does the pharmacological future of treating chronic hepatitis C look like?Semantic proximity Read

Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C.Semantic proximity Read

Direct-Acting Antiviral Therapy in HCV Patients: A Retrospective Study of the Pre- and Post-Treatment Impact in Saudi ArabiaSemantic proximity Read

Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study.Semantic proximity Read

Expert opinion on the treatment of patients with chronic hepatitis C.Semantic proximity Read

Are There Still Difficult-to-Treat Patients with Chronic Hepatitis C in the Era of Direct-Acting Antivirals?Semantic proximity Read

Development of a machine learning model to predict short duration HCV treatment responseSemantic proximity Read

Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings.Semantic proximity Read

Efficacy and safety of direct-acting antiviral regimen for patients with hepatitis C virus genotype 2: A systematic review and meta-analysisSemantic proximity Read

An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens.Semantic proximity Read

Direct-acting antiviral therapy in HCV patients: a retrospective study of the pre- and post-treatment impact in Saudi Arabia.Semantic proximity Read